Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DGAT1 | O75907 | 1/20 | 0.42 |
| ▸ | ELANE | P08246 | 1/20 | 0.41 |
| ▸ | USP2 | O75604 | 1/20 | 0.38 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.38 |
| ▸ | HDAC6 | Q9UBN7 | 2/20 | 0.38 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.38 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.38 |
| ▸ | SOAT1 | P35610 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.32 |
| ▸ | TSHR | P16473 | 2/20 | 0.32 |
| ▸ | HPGD | P15428 | 1/20 | 0.31 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.31 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.31 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.31 |
| ▸ | CA1 | P00915 | 1/20 | 0.31 |
| ▸ | CA2 | P00918 | 1/20 | 0.31 |
| ▸ | CA7 | P43166 | 1/20 | 0.31 |
| ▸ | GAA | P10253 | 2/20 | 0.31 |
| ▸ | MEN1 | O00255 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5452 | 1.00 | DGAT1 (0.42) | DGAT1ELANEUSP2SMN1; SMN2HDAC6 | |
| SCHEMBL1145251 | 0.97 | DGAT1 (0.40) | DGAT1ELANEUSP2SMN1; SMN2HDAC6 | |
| SCHEMBL28072361 | 0.97 | DGAT1 (0.40) | DGAT1ELANEUSP2SMN1; SMN2HDAC6 | |
| SCHEMBL28239854 | 0.97 | DGAT1 (0.40) | DGAT1ELANEUSP2SMN1; SMN2HDAC6 | |
| SCHEMBL29482425 | 0.97 | DGAT1 (0.40) | DGAT1ELANEUSP2SMN1; SMN2HDAC6 | |
| SCHEMBL31469549 | 0.97 | DGAT1 (0.40) | DGAT1ELANEUSP2SMN1; SMN2HDAC6 | |
| SCHEMBL29808062 | 0.97 | DGAT1 (0.40) | DGAT1ELANEUSP2SMN1; SMN2HDAC6 | |
| Hydrochloric Acid SCHEMBL28367906 | 0.97 | DGAT1 (0.40) | DGAT1ELANEUSP2SMN1; SMN2HDAC6 | |
| SCHEMBL29740062 | 0.97 | DGAT1 (0.40) | DGAT1ELANEUSP2SMN1; SMN2HDAC6 | |
| Ammonia Solution, Strong SCHEMBL28101892 | 0.97 | DGAT1 (0.40) | DGAT1ELANEUSP2SMN1; SMN2HDAC6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 34 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4704142-A1 | LAMINATE, METHOD FOR MANUFACTURING LAMINATE, AND METHOD FOR MANUFACTURING SEMICONDUCTOR DEVICE | Toray Industries, Inc. (JP) | 2026-03-04 | — | — | EP | disclosed |
| US-12534399-B2 | Laminate and manufacturing method of semiconductor device | TORAY INDUSTRIES, INC. (JP) | 2026-01-27 | — | — | US | disclosed |
| US-20250361224-A1 | PYRIMIDINE COMPOUND | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 2025-11-27 | — | — | US | disclosed |
| WO-2024225363-A1 | LAMINATE, METHOD FOR MANUFACTURING LAMINATE, AND METHOD FOR MANUFACTURING SEMICONDUCTOR DEVICE | 東レ株式会社 | 2024-10-31 | — | — | WO | disclosed |
| WO-2024203435-A1 | METHOD FOR PRODUCING TRANSFER LAMINATE, TRANSFER LAMINATE, AND SEMICONDUCTOR DEVICE PRODUCTION METHOD | 東レ株式会社 | 2024-10-03 | — | — | WO | disclosed |
| US-12060457-B2 | Resin composition for display substrate, resin film for display substrate and laminate body containing this, image display device, organic EL display, and manufacturing method of these | TORAY INDUSTRIES, INC. (JP) | 2024-08-13 | — | — | US | disclosed |
| US-20240186172-A1 | LAMINATE, RESIN COMPOSITION, AND METHOD FOR MANUFACTURING SEMICONDUCTOR DEVICE | TORAY INDUSTRIES, INC. (JP) | 2024-06-06 | — | — | US | disclosed |
| US-20240166556-A1 | LAMINATE AND MANUFACTURING METHOD OF SEMICONDUCTOR DEVICE | TORAY INDUSTRIES, INC. (JP) | 2024-05-23 | — | — | US | disclosed |
| CN-114341270-B | Resin film, electronic device, method for producing resin film, and method for producing electronic device | 东丽株式会社 | 2024-03-08 | — | — | CN | disclosed |
| EP-4316815-A1 | LAMINATE AND MANUFACTURING METHOD OF SEMICONDUCTOR DEVICE | Toray Industries, Inc. (JP) | 2024-02-07 | — | — | EP | disclosed |
| CN-113474156-B | Polyamic acid resin composition, polyimide resin film and method for producing same, laminate, and electronic device and method for producing same | 东丽株式会社 | 2022-04-29 | — | — | CN | disclosed |
| CN-114341270-A | Resin film, electronic device, method for producing resin film, and method for producing electronic device | 东丽株式会社 | 2022-04-12 | — | — | CN | disclosed |
| US-20200383993-A1 | 5-HT2C RECEPTOR AGONISTS AND COMPOSITIONS AND METHODS OF USE | ARENA PHARMACEUTICALS, INC. | 2020-12-10 | — | — | US | disclosed |
| US-10624900-B2 | 5-HT2C receptor agonists and compositions and methods of use | ARENA PHARMACEUTICALS, INC. (US) | 2020-04-21 | — | — | US | disclosed |
| US-20200078368-A1 | 5-HT2C RECEPTOR AGONISTS AND COMPOSITIONS AND METHODS OF USE | ARENA PHARMACEUTICALS, INC. | 2020-03-12 | — | — | US | disclosed |
| US-10272094-B2 | 5-HT2C receptor agonists and compositions and methods of use | ARENA PHARMACEUTICALS, INC. (US) | 2019-04-30 | — | — | US | disclosed |
| US-20180214455-A1 | 5-HT2C RECEPTOR AGONISTS AND COMPOSITIONS AND METHODS OF USE | ARENA PHARMACEUTICALS, INC. | 2018-08-02 | — | — | US | disclosed |
| CN-106794181-A | MTH1 inhibitors for the treatment of inflammatory and autoimmune conditions | 托马斯·黑勒戴药物研究基金会 | 2017-05-31 | — | — | CN | disclosed |
| US-5879852-A | POLYMERIC BINDER HAVING ACID-LABILE GROUPS | AGFA-GEVAERT AG (DE) | 1999-03-09 | — | — | US | disclosed |
| US-5654121-A | A HYDROXY- OR ESTER-CONTAINING STYRENE-BASED POLYMER HAVING ACID-LABILE GROUPS AND A PHOTOSENSITIVE COMPOUND RELEASING A STRONG ACID UPON IRRADIATION; STORAGE STABILITY; HEAT RESISTANCE; LOW DARK EROSION; PRINTING PLATES; PHOTORESISTS | AGFA-GEVAERT AG (DE) | 1997-08-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250361224-A1 | PYRIMIDINE COMPOUND | UMPS, TPMT, TYMS | DGAT1 2746/4885ELANE 4319/4885USP2 4343/4885 |
| US-10624900-B2 | 5-HT2C receptor agonists and compositions and methods of use | HTR2C, HTR2A, HCRTR2 | DGAT1 3333/4885ELANE 3188/4885USP2 2815/4885 |
| US-20180214455-A1 | 5-HT2C RECEPTOR AGONISTS AND COMPOSITIONS AND METHODS OF USE | HTR2C, HTR2A, HCRTR2 | DGAT1 3333/4885ELANE 3188/4885USP2 2815/4885 |
| US-20200078368-A1 | 5-HT2C RECEPTOR AGONISTS AND COMPOSITIONS AND METHODS OF USE | HTR2C, HTR2A, HCRTR2 | DGAT1 3333/4885ELANE 3188/4885USP2 2815/4885 |
| US-10272094-B2 | 5-HT2C receptor agonists and compositions and methods of use | HTR2C, HTR2A, HCRTR2 | DGAT1 3333/4885ELANE 3188/4885USP2 2815/4885 |
| US-20200383993-A1 | 5-HT2C RECEPTOR AGONISTS AND COMPOSITIONS AND METHODS OF USE | HTR2C, HTR2A, HCRTR2 | DGAT1 3333/4885ELANE 3188/4885USP2 2815/4885 |
| US-12534399-B2 | Laminate and manufacturing method of semiconductor device | LCP1, CDH1, L1CAM | DGAT1 3135/4885ELANE 3399/4885USP2 2320/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.